UroGen Pharma Reports Third Quarter 2023 Financial Results
Go back to UroGen Pharma Reports Third Quarter 2023 Financial Results| (NASDAQ: URGN) | Delayed: 46.44 -3.85 (7.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.29 | 52 Week High | $ | |||
| Open | $49.71 | 52 Week Low | $ | |||
| Day High | $49.71 | P/E | N/A | |||
| Day Low | $46.20 | EPS | $ | |||
| Volume | 698,392 | |||||

